Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5 on the Study Record, reflecting a minor page update. No substantive study content or eligibility details appear to be changed.
    Difference
    0.1%
    Check dated 2026-06-08T15:18:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4 replacing the previous Revision: v3.5.3. This indicates a minor system update rather than changes to study data on the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:27:52.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page footer revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor technical/version change without affecting the posted study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:22:01.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:35:58.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0; no substantive content changes are evident.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:59.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T19:28:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.